Literature DB >> 29731885

MicroRNA-192 inhibits the proliferation, migration and invasion of osteosarcoma cells and promotes apoptosis by targeting matrix metalloproteinase-11.

Guowei Shang1, Yang Mi2, Yingwu Mei2, Guanghui Wang1, Yadong Wang2, Xinjie Li2, Yisheng Wang1, Yuebai Li2, Guoqiang Zhao3.   

Abstract

MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression during stem cell growth, proliferation and differentiation. miRNAs are also involved in the development and progression of a number of cancer types, including osteosarcoma (OS). miR-192 is significantly downregulated in various tumors, including lung, bladder and rectal cancer. miR-192 expression is associated with the migration and invasion of OS cells. However, the expression of miR-192 and its effects on the development of OS have not been reported. In the present study, the involvement of miR-192 and its molecular mechanisms in the development of OS was investigated. The results indicate that miR-192 expression was significantly downregulated in OS tissues compared with non-tumor tissues (P<0.05). Next, a miR-192 agomir was transfected into the OS cell line MG-63 to upregulate miR-192. The effects of miR-192 overexpression were then investigated by examining cell proliferation, apoptosis, migration and invasion. Matrix metalloproteinase (MMP)-11 belongs to a family of nine or more highly homologous Zn2+-endopeptidases. It was demonstrated that the mRNA and protein expression of MMP-11 were upregulated in OS tissues compared with non-tumor tissues (P<0.05). MMP-11 was predicted by TargetScan and miRanda as a miR-192 target, which was confirmed by western blotting and dual-luciferase assays. Finally, it was demonstrated that the overexpression of miR-192 was able to downregulate MMP-11 expression and reduce proliferation, migration and invasion, and promote apoptosis in OS cells. Together, these data indicate that miR-192 may be a tumor suppressor that inhibits the progression and invasion of OS by targeting MMP-11. Therefore, miR-192 may be useful for the diagnosis and treatment of OS.

Entities:  

Keywords:  apoptosis; invasion; matrix metalloproteinase-11; miR-192; migration; osteosarcoma; proliferation

Year:  2018        PMID: 29731885      PMCID: PMC5920878          DOI: 10.3892/ol.2018.8239

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  38 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans.

Authors:  A Fire; S Xu; M K Montgomery; S A Kostas; S E Driver; C C Mello
Journal:  Nature       Date:  1998-02-19       Impact factor: 49.962

3.  Regulation of growth of human bladder cancer by miR-192.

Authors:  Yongchao Jin; Jiasun Lu; Jiling Wen; Yinzhou Shen; Xiaofei Wen
Journal:  Tumour Biol       Date:  2015-01-09

4.  Serum-based microRNA signatures in early diagnosis and prognosis prediction of colon cancer.

Authors:  Petra Vychytilova-Faltejskova; Lenka Radova; Milana Sachlova; Zdenka Kosarova; Katerina Slaba; Pavel Fabian; Tomas Grolich; Vladimir Prochazka; Zdenek Kala; Marek Svoboda; Igor Kiss; Rostislav Vyzula; Ondrej Slaby
Journal:  Carcinogenesis       Date:  2016-08-01       Impact factor: 4.944

Review 5.  MicroRNAs in non-small cell lung cancer and idiopathic pulmonary fibrosis.

Authors:  Keiko Mizuno; Hiroko Mataki; Naohiko Seki; Tomohiro Kumamoto; Kazuto Kamikawaji; Hiromasa Inoue
Journal:  J Hum Genet       Date:  2016-08-04       Impact factor: 3.172

6.  Low miR-34a and miR-192 are associated with unfavorable prognosis in patients suffering from osteosarcoma.

Authors:  Yuan Wang; Lian-Shun Jia; Wen Yuan; Zhao Wu; Hai-Bo Wang; Tao Xu; Jing-Chuan Sun; Ke-Fu Cheng; Jian-Gang Shi
Journal:  Am J Transl Res       Date:  2015-01-15       Impact factor: 4.060

Review 7.  Current treatment of osteosarcoma.

Authors:  W S Ferguson; A M Goorin
Journal:  Cancer Invest       Date:  2001       Impact factor: 2.176

Review 8.  Primary bone osteosarcoma in the pediatric age: state of the art.

Authors:  Alessandra Longhi; Costantino Errani; Massimiliano De Paolis; Mario Mercuri; Gaetano Bacci
Journal:  Cancer Treat Rev       Date:  2006-07-24       Impact factor: 12.111

9.  Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers.

Authors:  George Adrian Calin; Cinzia Sevignani; Calin Dan Dumitru; Terry Hyslop; Evan Noch; Sai Yendamuri; Masayoshi Shimizu; Sashi Rattan; Florencia Bullrich; Massimo Negrini; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-18       Impact factor: 11.205

Review 10.  Grading of bone tumors.

Authors:  K K Unni; D C Dahlin
Journal:  Semin Diagn Pathol       Date:  1984-08       Impact factor: 3.464

View more
  10 in total

1.  Knockdown of Long Non-Coding RNA AFAP1-AS1 Promoted Viability and Suppressed Death of Cardiomyocytes in Response to I/R In Vitro and In Vivo.

Authors:  Zhigong Chen; Xinkuan Wang; Xiaodong Hou; Fan Ding; Kang Yi; Peng Zhang; Tao You
Journal:  J Cardiovasc Transl Res       Date:  2020-05-13       Impact factor: 4.132

Review 2.  Molecular mechanism of microRNAs regulating apoptosis in osteosarcoma.

Authors:  Xueyang Cai; Wei Yin; Chao Tang; Yubao Lu; Yuqi He
Journal:  Mol Biol Rep       Date:  2022-04-26       Impact factor: 2.742

3.  MicroRNA-431-5p Inhibits the Tumorigenesis of Osteosarcoma Through Targeting PANX3.

Authors:  Shengliang Sun; Lei Fu; Gen Wang; Jianli Wang; Liping Xu
Journal:  Cancer Manag Res       Date:  2020-09-08       Impact factor: 3.989

Review 4.  Dissecting the functional role of microRNA 21 in osteosarcoma.

Authors:  Durairaj Sekar; Panagal Mani; M Biruntha; P Sivagurunathan; M Karthigeyan
Journal:  Cancer Gene Ther       Date:  2019-03-25       Impact factor: 5.854

Review 5.  Regulators at Every Step-How microRNAs Drive Tumor Cell Invasiveness and Metastasis.

Authors:  Tomasz M Grzywa; Klaudia Klicka; Paweł K Włodarski
Journal:  Cancers (Basel)       Date:  2020-12-10       Impact factor: 6.639

6.  Drug repurposing for coronavirus (SARS-CoV-2) based on gene co-expression network analysis.

Authors:  Habib MotieGhader; Esmaeil Safavi; Ali Rezapour; Fatemeh Firouzi Amoodizaj; Roya Asl Iranifam
Journal:  Sci Rep       Date:  2021-11-08       Impact factor: 4.379

7.  MicroRNAs expression influence in ulcerative colitis and Crohn's disease: A pilot study for the identification of diagnostic biomarkers.

Authors:  Ana Elisa Valencise Quaglio; Felipe Jose Santaella; Maria Aparecida Marchesan Rodrigues; Ligia Yukie Sassaki; Luiz Claudio Di Stasi
Journal:  World J Gastroenterol       Date:  2021-12-07       Impact factor: 5.742

8.  Identification and Validation of a Potent Multi-miRNA Signature for Prediction of Prognosis of Osteosarcoma Patients.

Authors:  Xinle Luo; Jiuyang Tang; Huabing Xuan; Jianlin Liu; Xi Li
Journal:  Med Sci Monit       Date:  2020-02-26

9.  Circular RNA hsa_circ_0000282 contributes to osteosarcoma cell proliferation by regulating miR-192/XIAP axis.

Authors:  Houkun Li; Limin He; Yuan Tuo; Yansheng Huang; Bing Qian
Journal:  BMC Cancer       Date:  2020-10-23       Impact factor: 4.430

10.  Diagnostic and Prognostic Role of miR-192 in Different Cancers: A Systematic Review and Meta-Analysis.

Authors:  Lili Wang; Yuhan Liu; Chen Lyu; Alexander Buchner; Heike Pohla
Journal:  Biomed Res Int       Date:  2021-02-04       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.